• LAST PRICE
    6.6600
  • TODAY'S CHANGE (%)
    Trending Down-0.2800 (-4.0346%)
  • Bid / Lots
    6.5300/ 3
  • Ask / Lots
    6.8000/ 2
  • Open / Previous Close
    6.8500 / 6.9400
  • Day Range
    Low 6.6100
    High 6.8500
  • 52 Week Range
    Low 5.0100
    High 12.7500
  • Volume
    205,093
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 6.94
TimeVolumeCMPS
09:32 ET40376.75
09:34 ET3006.8104
09:39 ET117256.75
09:43 ET1006.73
09:45 ET5536.74
09:52 ET10006.74
09:54 ET13046.715
09:56 ET11226.72
09:59 ET37846.773
10:03 ET7416.71
10:08 ET41976.78
10:10 ET36006.7515
10:12 ET5506.765
10:14 ET4286.75
10:15 ET8006.745
10:17 ET2006.75
10:19 ET1006.75
10:24 ET6856.75
10:28 ET3066.75
10:32 ET1016.74
10:33 ET5506.725
10:35 ET1006.72
10:37 ET13786.745
10:39 ET18746.7315
10:42 ET1006.745
10:44 ET3006.745
10:46 ET3316.74
10:48 ET8006.79
10:50 ET2006.785
10:53 ET2906.785
10:55 ET1006.77
11:02 ET4006.7703
11:06 ET6426.77
11:08 ET5006.76
11:09 ET2456.75
11:13 ET1006.75
11:18 ET1006.76
11:20 ET9246.71
11:24 ET2006.705
11:26 ET5416.7
11:27 ET6006.72
11:31 ET10006.735
11:33 ET4006.73
11:36 ET4166.725
11:40 ET4326.685
11:42 ET7756.66
11:44 ET3256.6608
11:45 ET21506.68
11:47 ET14006.65
11:49 ET11006.66
11:54 ET12006.659
11:56 ET4006.6613
11:58 ET18506.68
12:00 ET4006.6944
12:02 ET9216.68
12:07 ET3546.69
12:12 ET108976.74
12:16 ET8146.71
12:18 ET2406.71
12:20 ET12496.69
12:21 ET2006.69
12:23 ET3496.6976
12:27 ET18656.68
12:30 ET3756.68
12:34 ET1006.68
12:36 ET25006.65
12:38 ET1006.65
12:39 ET4486.66
12:41 ET11376.67
12:43 ET2006.68
12:48 ET8006.67
12:52 ET106876.65
12:54 ET1006.65
12:56 ET8976.634
12:59 ET5006.65
01:03 ET20016.67
01:08 ET1066.67
01:10 ET9186.675
01:12 ET4276.675
01:15 ET16046.67
01:17 ET7006.67
01:19 ET4006.66
01:24 ET1006.67
01:26 ET8516.6524
01:28 ET8736.665
01:30 ET9006.665
01:32 ET15946.6783
01:35 ET5766.68
01:37 ET1006.67
01:39 ET1006.68
01:44 ET4136.66
01:46 ET20036.7
01:48 ET1226.7
01:50 ET1006.7
01:51 ET1006.7
01:53 ET45276.735
01:57 ET3006.73
02:02 ET3006.715
02:06 ET75016.74
02:08 ET7956.7101
02:13 ET2006.72
02:15 ET5006.73
02:18 ET2006.7115
02:22 ET1006.72
02:24 ET1006.74
02:26 ET8196.735
02:27 ET6006.7336
02:29 ET2006.72
02:33 ET6586.71
02:38 ET4336.7
02:42 ET1006.695
02:44 ET4006.7
02:45 ET1006.695
02:47 ET7006.68
02:51 ET4016.67
02:54 ET2006.67
02:56 ET15566.67
02:58 ET21176.66
03:00 ET1346.665
03:03 ET2006.67
03:05 ET7006.67
03:07 ET11006.67
03:09 ET20006.65
03:12 ET10166.64
03:14 ET1006.63
03:18 ET12976.61
03:20 ET4206.62
03:21 ET1006.61
03:23 ET10586.62
03:27 ET3106.61
03:30 ET16036.63
03:32 ET2506.63
03:34 ET3006.63
03:36 ET8226.62
03:38 ET4006.64
03:39 ET27146.6532
03:41 ET2006.65
03:43 ET13596.66
03:45 ET5006.66
03:48 ET4006.665
03:50 ET11006.66
03:52 ET9856.68
03:54 ET8006.67
03:56 ET11006.6701
03:57 ET6006.66
03:59 ET42446.66
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCMPS
Compass Pathways PLC
467.7M
-2.8x
---
United StatesLENZ
LENZ Therapeutics Inc
477.7M
-1.2x
---
United StatesTERN
Terns Pharmaceuticals Inc
478.0M
-6.5x
---
United StatesSLRN
ACELYRIN Inc
456.5M
-1.6x
---
United StatesNGNE
Neurogene Inc
482.6M
-9.3x
---
United StatesALT
Altimmune Inc
452.4M
-3.8x
---
As of 2024-06-14

Company Information

Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Contact Information

Headquarters
3Rd Floor, 1 Ashley RoadALTRINCHAM, United Kingdom WA14 2DT
Phone
---
Fax
---

Executives

Interim Independent Chairman of the Board
David Norton
Chief Executive Officer, Executive Director
Kabir Nath
Chief Financial Officer, Principal Accounting Officer
Teri Loxam
General Counsel, Chief Legal Officer
Matthew Owens
Chief Medical Officer
Guy Goodwin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$474.6M
Revenue (TTM)
$0.00
Shares Outstanding
68.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.31
EPS
$-2.37
Book Value
$3.64
P/E Ratio
-2.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.